CERE
Cerevel Therapeutics Holdings Inc
Price:  
44.96 
USD
Volume:  
15,090,400.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CERE Probability of Bankruptcy

The Probability of Bankruptcy of Cerevel Therapeutics Holdings Inc (CERE) is 78.57% . This number represents the probability that CERE will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating CERE's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

CERE - ESG ratings

ESG ratings are directly linked to the cost of capital and CERE's ability to raise funding, both of which can significantly affect the probability of Cerevel Therapeutics Holdings Inc going bankrupt.

ESG Score 49.70
Environment Score 51.94
Social Score 63.96
Governance Score 33.21
Returns
Historical Returns (5 day) 1.26%
Historical Returns (MTD) 9.95%
Historical Returns (YTD) 6.04%
Historical Returns (13 week) 5.17%
Historical Returns (26 week) 6.79%
Historical Returns (52 week) -14.11%
Efficiency
Asset Turnover
Receiveable Turnover
Gross Margin
Operating Margin
Pretax Margin
Net Margin
Return on Asset (ROA) -45.07
Return on Equity (ROE) -98.94
Return on Investments (ROI) -57.37
Price Metrics
Market Cap (M) 8,191.26
Enterprise Value (M)
52 Week High 44.99
52 Week Low 38.50
Beta 1.18
Average Volume (10 day) 3.94
Average Volume (3 month) 1.61
Price / Earnings (P/E)
Price / Sales (P/S)
Earnings
EPS -2.72
Revenue CAGR (5 year)
Risk
Current Ratio 10.22
Quick Ratio 10.12